A detailed history of Los Angeles Capital Management LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 6,205 shares of TNDM stock, worth $229,957. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,205
Holding current value
$229,957
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$35.21 - $47.3 $218,478 - $293,496
6,205 New
6,205 $263,000
Q2 2022

Aug 05, 2022

SELL
$53.22 - $123.09 $111,336 - $257,504
-2,092 Closed
0 $0
Q1 2022

May 06, 2022

BUY
$101.89 - $150.09 $11,411 - $16,810
112 Added 5.66%
2,092 $243,000
Q4 2021

Feb 03, 2022

SELL
$118.18 - $153.21 $20,563 - $26,658
-174 Reduced 8.08%
1,980 $298,000
Q2 2021

Aug 05, 2021

SELL
$77.0 - $100.19 $10,626 - $13,826
-138 Reduced 6.02%
2,154 $210,000
Q1 2021

May 05, 2021

SELL
$81.28 - $104.34 $25,603 - $32,867
-315 Reduced 12.08%
2,292 $202,000
Q4 2020

Feb 04, 2021

SELL
$86.4 - $121.75 $66,960 - $94,356
-775 Reduced 22.92%
2,607 $249,000
Q3 2020

Nov 02, 2020

SELL
$95.43 - $116.09 $306,330 - $372,648
-3,210 Reduced 48.7%
3,382 $384,000
Q2 2020

Aug 05, 2020

SELL
$60.05 - $98.92 $1.28 Million - $2.11 Million
-21,293 Reduced 76.36%
6,592 $652,000
Q1 2020

May 04, 2020

BUY
$47.37 - $90.04 $713,155 - $1.36 Million
15,055 Added 117.34%
27,885 $1.79 Million
Q4 2019

Feb 07, 2020

BUY
$53.13 - $71.19 $67,475 - $90,411
1,270 Added 10.99%
12,830 $765,000
Q3 2019

Nov 07, 2019

BUY
$57.11 - $73.3 $448,884 - $576,138
7,860 Added 212.43%
11,560 $682,000
Q2 2019

Jul 29, 2019

SELL
$54.41 - $71.7 $183,361 - $241,629
-3,370 Reduced 47.67%
3,700 $239,000
Q1 2019

Apr 25, 2019

BUY
$32.25 - $73.56 $228,007 - $520,069
7,070 New
7,070 $449,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.38B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.